BMPR2 and pulmonary arterial hypertension: In line with this hypothesis, we have observed a marked decrease in the expression levels of anti-inflammatory Cav-1 and BMPR2 within the lung vascular endothelium, which appear to be instrumental for the expansion of an abnormal EC phenotype evident in PAH.